Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR αβ lymphocytes
✍ Scribed by Lionel Arlettaz; Jean Villard; Casimir de Rham; Sylvie Degermann; Bernard Chapuis; Bertrand Huard; Eddy Roosnek
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 265 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A subset of CD8^+^ T cells express the natural killer cell receptors CD94:NKG2A or CD94:NKG2C. We found that although many CD8^+^ T cells transcribe CD94 and NKG2C, expression of a functional CD94:NKG2C receptor is restricted to highly differentiated effector cells. CD94:NKG2A is expressed by a different subset consisting of CCR7^+^ memory cells and CCR7^–^ effector cells. Since NKG2A can only be induced on naive CD8^+^ T cells while CD94^–^ memory cells are refractory, it is likely that commitment to the CD94:NKG2A^+^ subset occurs during the first encounter with antigen. CCR7^+^CD94:NKG2A^+^ T cells recirculate through lymph nodes where upon activation, they produce large quantities of IFN‐γ. These cells occur as a separate CD94:NKG2A^+^ T cell lineage with a distinct TCR repertoire that differs from that of the other CD8^+^CD94^–^ T cells activated in situ.
📜 SIMILAR VOLUMES
Different HLA class I-specific killer inhibitory receptors (KIR) are expressed in vivo by a fraction of activated T cells, predominantly CD8 + , in which they may inhibit TCR-mediated cell functions. In an attempt to identify mechanisms leading to KIR expression in T cells, we analyzed the effect of